Digital Health Technologies for PSP and Lewy Body Dementia

This study is looking at digital health technologies, like wearable devices, to monitor movement in people with Progressive Supranuclear Palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB). The goal is to see if these technologies can accurately measure how well people are moving their arms and legs. This could help doctors track these conditions and test new treatments in the future. You might be able to join if you are between 40 and 89 years old and have been diagnosed with probable PSP, probable MCI-LB, or probable DLB. The researchers will measure your walking ability and how easily you can stand up from a chair at the beginning of the study. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will observe participants without providing any specific interventions. It plans to enroll 60 participants.
What's involved
You would need to be present for all study procedures, complete questionnaires, and assist during home data collection. Specific details on the number of visits or duration are not provided.
Compensation
Not stated in the trial record.
Follow-up
The primary measurements are taken at baseline, so there is no specified follow-up period after initial assessment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07240805

Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies

Not Yet Recruiting
Not specifiedAges 40–89Observational
BioSensics
~60 participants
Updated 2026-07-01 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
2-Minute Walk Test (2MWT)
Measured over Baseline.
+7 more outcomes measured
Progressive Supranuclear Palsy(PSP)
Dementia With Lewy Bodies (DLB)
PSP
Lewy Body Dementia (LBD)
Lewy Body Disease
2 sites across 2 states
Maryland1
Massachusetts1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Male and female participants aged 40-89 meeting clinical diagnostic criteria for probable PSP, probable MCI-LB or probable DLB.
Able to be present for all study procedures, complete questionnaires and assist during home data collection.
Eligible participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment.
Must have a caregiver or study partner who is willing and able to assist with all study-related procedures.
Ambulatory (able to take 10 steps with minimal support such as use of a cane)

Exclusion

Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment.
History of frequent falls defined as more than 5 falls per month, will not be eligible to participate in the study.
  • 2-Minute Walk Test (2MWT)Baseline.

    Participants will perform the 2-minute walk test (2MWT) while wearing a PAMSys pendant sensor, and two PAMSys Gait ankle sensors.

  • Timed Up & Go Test (TUG)Baseline.

    Participants will perform the (TUG) test while wearing a PAMSys pendant sensor, and two PAMSys Gait ankle sensors.

  • 5-times Sit-to-Stand Test (5xSTS)Baseline.

    Participants will perform the 5-times Sit-to-Stand Test (5xSTS) while wearing a PAMSys pendant sensor.

  • Box and Block test (BBT)Baseline.

    Participants will perform the Box and Block test (BBT) while wearing two PAMSys ULM wrist sensors.

  • 9-Hole Peg Test (9HPT)Baseline

    Participants will perform the 9-Hole Peg Test (9HPT) while wearing two PAMSys ULM wrist sensors.

  • Physical Activity Monitoring14 days

    Following the baseline visit, participants will be asked to wear a PAMSys pendant sensor for 14 days at home. The average daily number of steps will be measured using the PAMSys pendant.

  • Gait Monitoring14 days

    Following the baseline visit, participants will be asked to wear two PAMSys Gait ankle sensors for 14 days at home. Daily average stride velocity will be measured using the PAMSys Gait ankle sensors. The stride velocity unit is m/s.

  • Hand Function Monitoring14 days

    Following the baseline visit, participants will be asked to wear two PAMSys ULM wrist sensors for 14 days at home. Average daily number of hand goal-directed movements will be measured using the AMSys ULM wrist sensors.